CD28 and neoplasm: Compared with CD3ζ, CD28-CD3ζ, DNAM1-CD3ζ and 2B4-CD3ζ, CAR-NK expressing DNAM1-2B4-CD3ζ chimeric antigen receptor has the best anti-tumor effect (162).